Effects of antioxidant supplementation with Astaxanthin on blood vessels in renal transplant patients

Effects of supplementation with Astaxanthin on oxidative stress and vascular structure and function in renal transplant patients

Status

Recruiting

Phases

Phase 3

Study type

Interventional

Source

ANZCTR

Registry ID

ACTRN12608000159358

Acronym

Xanthin Study

Enrollment

Registered

2008-04-03

Start date

2006-09-01

Completion date

Unknown

Last updated

2020-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Astaxanthin 4 mg tablets, 3 tablets daily over 12 months

Study design

Allocation

Randomised controlled trial

Intervention model

Parallel

Primary purpose

Treatment

Masking

Blinded (masking used)

Eligibility

Sex/Gender

All

Age

18 Years to 85 Years

Healthy volunteers

Inclusion criteria

Have undergone a renal transplant

Exclusion criteria

Individuals currently taking antioxidant supplements or have AV fistulas in both arms or are unable to be given anginine or participation or proposed participation in another clinical investigational drug study within 30 days prior to study entry.

Outcome results